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  During the late incubation period or initial phase of dengue 
virus infection, laboratory confirmation is through viral 
isolation in cell culture and/or molecular investigations, 
or immunofluorescence, or immunohistochemistry[1]. The 
dengue virus non-structural antigen NS1 that would develop 
before the appearance of dengue IgM and/or IgG is emerging 
as a suitable option for dengue diagnosis[2]. Platelet therapy 
is a standard clinical practice for dengue patients with 
severe thrombocytopenia[3]. However, during introductory 
screening, platelet count is not being done in many cases. 
This results in delays of platelet therapy. 
  In the course of the current (2010) spurt of dengue in 
New Delhi[4], simultaneous screening for NS1, IgM and IgG 
and platelet enumeration has been introduced at the Sant 
Parmanand Hospital, a 140-bedded tertiary care, private 
hospital in Delhi.   
  During the last fortnight of August 2010, samples from 175 
suspected patients were taken for testing by the combined 
‘dengue package’ that included assays for NS1, IgM, IgG 
and automated platelet enumeration. Blood samples were 
drawn into EDTA tubes and tested for dengue components 
employing the single-step method: immunochromatigrahic 
one step dengue NS1 Ag and IgG/IgM test, dengue duo, in 
accordance with the manufacturer’s instructions (Standard 
Diagnostics, Inc, www.standardia.com). The platelet 
enumeration was in the 5- or 3-differential analyzers, 
CoulterRAc TTm 5diff Autoloader (Beckman Coulter, 
Fullerton, CA) or BC-3000Plus (Mindary, Shenzhen, China). 
The reports were available within 1-2 hours.
  Patients’ age ranged from 6 months to 73 years, mean 28.7 
years: standard deviation=13.4, SEM=1.01. A total of 86 
patients were NS1-positive in different combinations, while 
89 were NS1-negative. Among 86 NS 1-positive patients, 
29 were IgM-positives and 57 were IgG-negative. Ten were 
IgG-positive and 76 were IgG-negative. Four patients with 
IgG- positive were also IgM- positive. There were 9 IgM-
positive patients  and 80 IgM-negative in 89 NS1-negative 
patients; while 15 were IgG-positive and 74 IgG-negative. 
There were 6 patients who were positive to three markers 
while 72 were negative and 53 patients were positive 
exclusively to NS1.
 The platelet count among 86 NS1-positives [(115依6) 伊109/L]
was lower than the 89 NS1- negatives[(149依11) 伊109/L] 
(P=0.0086).  Counts of 29 patients co-positives to NS1 and 
IgM was (102依10)伊109/L, counts of 15 patients with NS-1 
negative but IgG- positives was (44依9)伊109/L , 9 patients 
with NS1- negative and IgM-positive was (62依16)伊109/L; 
count of 6 patients with NS1 positive, IgM positive and IgG 
positive was (76依27) ×109/L; count of 10 patients with NS1 
positive and IgG positive was (89依21)×109/L. 
  86 NS1-positive patients included 57 who were negative for 
IgM and would have otherwise been missed. Four exclusive 
IgG-positives, with a secondary viral infection, would 
have been overlooked. The NS1 test is helpful in dengue 
diagnosis, otherwise they would be labeled as negative. 
The concurrent NS1-positive and IgM positive status of 29 
patients reinforced the serological diagnosis during the 
earlier phase of illness. 
 It would not be possible to rule out dengue infection in 
above 72 triple-negative cases without testing for viral 
replication in cell culture and/or molecular investigations or 
immunofluorescence, or immunohistochemistry[1], for which 
facilities are not available in our hospital. Such patients 
should be investigated for acute febrile illnesses including 
malaria, urinary tract infection, enteric fever, Chikungunya 
virus and the influenza virus H1N1 infection.
  With dengue package, a single laboratory test for serology 
and platelet enumeration has been an asset for clinicians 
and patients. Based of results, platelet transfusion can be 
started straightaway. 
  There has been a wide variation in the platelet counts 
of  the patients. The platelet count in 8 NS1-negatives 
was <20伊109/L, 4 in NS1-positives, 1 in patients with NS1 
and IgM positive, 3 in patients with NS1 negative but IgM 
positive, 6 in patients with NS1 negative but IgG positive, 1 
in patients with NS1, IgM and IgG positive, and 2 in patients 
with NS1 and IgG positive. This would help to differentiate 
between patients with dengue-associated thrombocytopenia 
and those with severe bleeding episodes associated with 
trauma, invasive intensive care procedures or emergency 
surgery. Moreover, in patients with platelet count <20
伊10
9/L, decreased megakaryocytic production, splenic 
sequestration, non-immune or immune destruction of 
platelets should be examined.   
  To conclude, use of dengue package is precious in dengue 
virus diagnosis in health care centres lacking sophisticated 
laboratory facilities. This would help physicians to offer 
rational therapy to patients, and government agencies 
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